Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,102.86 -856.53 (-1.32%) CMC Crypto 200
1,331.03 -29.29 (-2.15%)
TMDX Jan 2025 110.000 call
| Previous close | 43.95 |
| Open | 43.95 |
| Bid | 41.90 |
| Ask | 45.60 |
| Strike | 110.00 |
| Expiry date | 2025-01-17 |
| Day's range | 43.95 - 43.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 18, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 1,002 shares of its common stock and an aggregate of 657 restricted stock units to 1 employee, each as a material inducement for the employee's entry into employment with TransMedics. The grants
ZacksTransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
GuruFocus.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
Director Edward Basile of TransMedics Group Inc (NASDAQ:TMDX) sold 1,193 shares of the company on June 5, 2024, according to a recent SEC Filing.
